BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5527427)

  • 1. [Hypotensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Palagi L; D'Elia M; Lanzara P; Criscione SM
    Clin Ter; 1970 Jun; 53(6):515-25. PubMed ID: 5527427
    [No Abstract]   [Full Text] [Related]  

  • 2. [Clinical experience with a new hypotensive drug: 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST-155)].
    Langer-Costanzi M
    Clin Ter; 1970 Dec; 55(5):419-31. PubMed ID: 5516107
    [No Abstract]   [Full Text] [Related]  

  • 3. [On hypertension therapy with 2-(2,6-dichlorophenylamino-)2-imidazoline hydrochloride (Catapresan)].
    Fritsch H; Bachmann GW; Lenhard J
    Med Klin; 1969 May; 64(18):842-7. PubMed ID: 4389564
    [No Abstract]   [Full Text] [Related]  

  • 4. Blind trial with 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155) in essential hypertension. Effects on arterial blood pressures at rest and during exercise and on physical work capacity.
    Koch G
    Arzneimittelforschung; 1970 Dec; 20(12):1857-9. PubMed ID: 5537080
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinico-experimental study of a hypotensive drug: 2(2,6-dichloro-phenylamino)-2-imidazoline hydrochloride].
    Caparello O; Contino A; Viola A; Pirro G
    Clin Ter; 1971 Jul; 57(6):553-62. PubMed ID: 5136489
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of the electrocardiogram and radionephrogram during long-term treatment of arterial hypertension with 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride].
    Curri G
    Clin Ter; 1970 Jun; 53(6):527-46. PubMed ID: 5527428
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preliminary clinical experiences on the antihypertensive effect of 2-(2-6 diclorophenylamino)-imidazoline].
    Corsini G; Di Filippo A; Cioffi A
    Rass Int Clin Ter; 1971 Feb; 51(4):237-46. PubMed ID: 5576946
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemodynamic changes following adminstration of dichlorophenylamino-imidazoline hydrochloride in acute and chronic experiments].
    Schneider KW; Gattenlöhner W; Müller W
    Verh Dtsch Ges Inn Med; 1967; 73():611-6. PubMed ID: 4873599
    [No Abstract]   [Full Text] [Related]  

  • 9. [Administration of a new hypotensive agent 2-(2,6-dichlorphenylamino) imidazoline chlorhydrate in the treatment of essential arterial hypertension].
    Borrello G
    Clin Ter; 1971 Apr; 57(1):9-29. PubMed ID: 5090286
    [No Abstract]   [Full Text] [Related]  

  • 10. [First observations on an antihypertensive effect of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride in man].
    Michel D; Zimmermann W; Nassehi A; Seraphim P
    Dtsch Med Wochenschr; 1966 Sep; 91(35):1540-7. PubMed ID: 5917865
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the therapy of hypertension with an imidazoline derivative].
    Krause W; Krämer D; Grünitz B
    Med Klin; 1969 Jul; 64(28):1274-6. PubMed ID: 5799785
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies on differential therapy of hypertension with dichlorophenylaminoimidazoline hydrochloride (Haemiton)].
    Seifert A; Hafemeister G; Kirchner D; Wöstenberg D; Tiedcke H; Ullmann W
    Dtsch Gesundheitsw; 1970 Dec; 25(50):2369-74. PubMed ID: 5509665
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experimentation with a new imidazoline derivative (ST155) in the treatment of arterial hypertension].
    Ferreira EB; Eichemberg R; Berlitz MF
    Hospital (Rio J); 1969 Jun; 75(6):2139-51. PubMed ID: 5311472
    [No Abstract]   [Full Text] [Related]  

  • 14. [Catapresan--a new hypotensive agent].
    Tarkowska A
    Pol Tyg Lek; 1969 Jun; 24(24):934-6. PubMed ID: 4896410
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experimentation with a new anti-hypertensive agent (St 155)].
    Vettore L
    Minerva Med; 1972 Apr; 63(29):1669-78. PubMed ID: 5025774
    [No Abstract]   [Full Text] [Related]  

  • 16. [Our first experiences with the new hypotensive drug Catapresan].
    Grujić M; Robović Z; Perinović M; Rizvanbegović B; Sarić V; Vasiljević M
    Med Arh; 1968; 22(3):75-80. PubMed ID: 5191771
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of prolonged treatment with 2-(2,6-dichlorophenylamine)-2-imidazoline HCl on renal hemodynamics in arterial hypertension].
    Ludwig H
    Arzneimittelforschung; 1968 May; 18(5):600-4. PubMed ID: 5755891
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of arterial hypertension with ST-155].
    Fonnesu C; Solinas F
    Clin Ter; 1970 Sep; 54(5):455-9. PubMed ID: 4949933
    [No Abstract]   [Full Text] [Related]  

  • 19. [First clinical experiences with a new hypotensive substance in severe forms of hypertension].
    Bergström J; Bergquist-Poppen M; Bucht H
    Arzneimittelforschung; 1966 Dec; 16(12):1606-10. PubMed ID: 6014792
    [No Abstract]   [Full Text] [Related]  

  • 20. [Clinical evaluation of imidazoline hydrochloride, alone or in combination with hydrochlorothiazide, in outpatient hypertensive patients].
    Miziara LJ; Zorzo DO; Silva EE
    Arq Bras Cardiol; 1973 Feb; 26(1):57-61. PubMed ID: 4731937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.